Sanofi

Sanofi iDEA-TECH Awards North America

Stylized blue human head profile with abstract neural network connections on gradient background

What Is It?

Sanofi is committed to collaborating with partners to advance cutting-edge discoveries. The Sanofi Innovations in Data Exploration and Analytics (iDEA) Awards program, launched in 2018, provides seed funding to innovators at research centers and early start-ups across North America to transform breakthrough digital, data science tools and new technologies into solutions that accelerate the R&D pipeline and improve people’s lives. In 2022, the iDEA awards (NA) and iTECH awards (Europe) merged into the Sanofi global iDEA-TECH awards.

About the Program

  • Seed funding of $150.000 USD
  • 1 year project duration
  • Dedicated Sanofi Project Champion and resources (subject matter experts)
  • A stepping stone to further collaboration

The Next Project Call is Anticipated for November 2026

Examples of Partnering Opportunities

Predict patient outcomes

Predict & track disease progression & drug effects

Maximize drug value in the real world

Optimize clinical trial design

Drug target enabling platforms

Biomarker Identification

Test new digital/AI solutions

High throughput screening approaches

Analytic tools to understand drug mechanism or product quality

Testimonials

“The iDEA-TECH Awards initiative is providing a unique opportunity to work as a team to study itch in kids with atopic dermatitis in the comfort of their homes by incorporating our Emerald AI technology. It has been exciting to work so closely with the Sanofi team around a shared commitment to breaking new grounds for this important population.”

Dina Katabi, PhD, Thuan and Nicole Pham Professor, MIT President and co-Founder, Emerald Innovations, Inc. 

Sanofi iDEA-TECH Awards

Recent award recipients share how winning this award and collaborating with Sanofi researchers has impacted their work.

iDEA-TECH Recipients for 2025-2026

Isaac Lutz

Aptamino

Jeffrey Petrella

Duke University Health

Marinka Zitnik

Harvard University, Harvard Medical School

Jinfeng Zhang

Insilicom LLC

Joel Bader

Johns Hopkins University

Anjalie Field

Johns Hopkins University

Hai-Quan Mao

Johns Hopkins University

Morgan Chandler

MIMETAS Operations Us, Co

Anna Jezierski

National Research Council of Canada

Scott Tenenbaum

sxRNA Technologies, Inc.

Narendra Tallapragada

Tessel Biosciences

Wenpeng Yin and Wenrui Hao

The Pennsylvania State University

Le Bao

The Pennsylvania State University

Omar Din

University of California, San Diego

Jingchuan Guo

Regenstrief Institute

Kevin Weeks

University of North Carolina at Chapel Hill

Matthew Champion

University of Notre Dame

Vadim Cherezov

University of Southern California

Joint Publications

Uncovering New Therapeutic Targets for Amyotrophic Lateral Sclerosis (ALS) and Neurological Diseases Using Real-World Data

UCLA, Jennifer Wilson, 2025

Evaluating the robustness of an AI pathfinder application on eligibility criteria in multiple myeloma trials using real-world data and historical trials

Weill Cornell Medical College, Fei Wang, 2024

Characterizing the connection between Parkinson’s disease progression and healthcare utilization

Harvard, Brett Beaulieu-Jones, 2024​

Learning the Language of Antibody Hypervariability

MIT, Berger, 2024

Disease Progression Strikingly Differs in Research and Real-World Parkinson’s Populations

Harvard Medical School, Brett Beaulieu-Jones and Isaac Kohane, 2024

A Critical Review of Methods for Real-World Applications to Generalize or Transport Clinical Trial Findings to Target Populations of Interest

Stanford, Manisha Desai, 2023

Characterizing Real-World Safety Profile of Oral Janus Kinase Inhibitors Among Adult Atopic Dermatitis Patients: Evidence Transporting From the Rheumatoid Arthritis Population

Stanford, Manisha Desai, 2022

Transporting Observational Study Results To a Target Population of Interest Using Inverse Odds of Participation Weighting

Stanford, Manisha Desai, 2022

Accelerating Diagnosis of Parkinson’s Disease Through Risk Prediction

Harvard, Scott Lipnick, 2021

Calibration and Uncertainty in Neural Time-to-Event Modeling

Duke, Ben Goldstein, 2020

For more information about iDEA-TECH Awards